ImmunityBio (IBRX) Climbs 7.3% as Firm Nears Development of ‘World Bank of NK Cells’

ImmunityBio Inc. (NASDAQ:IBRX) is one of the 10 Must-Watch Stocks Right Now.

ImmunityBio surged by 7.29 percent on Friday to finish at $8.39 apiece, as investors took heart from the company’s optimism for the development of the “World Bank of Natural Killer (NK) Cells,” thanks to the success of its two manufacturing engineering programs.

In an updated report, ImmunityBio Inc. (NASDAQ:IBRX) said it successfully completed NK2022 and NK2023 programs, which evaluated that it could safely collect large volumes of immune cells and enrich them into NK cells.

ImmunityBio Inc. (NASDAQ:IBRX) said that 64 subjects completed apheresis collection across healthy and cancer patients, while collected cells were stored and used for process development and validation.

ImmunityBio (IBRX) Climbs 7.3% as Firm Nears Development of 'World Bank of NK Cells'

Following the study, the firm saw preserved NK cell activity and phenotype in both healthy donors and cancer patients, including those who have undergone therapy.

It noted that NK cells, even from cancer patients, can still attack and kill cancer cells effectively, similar to those from healthy donors.

“These data demonstrate that potent NK cell therapy can be manufactured at scale and administered safely, potentially offering a reliable autologous source of potent NK cells,” ImmunityBio Inc. (NASDAQ:IBRX) Executive Chairman Patrick Soon-Shiong said.

“The ability to generate up to 5 billion highly pure NK cells from a single apheresis collection, yielding up to 8-10 therapeutic doses within 12 days, opens the possibility of creating the ‘World Bank of Natural Killer Cells’, with NK cells able to be universally donated to any patient without HLA matching,” he added.

While we acknowledge the risk and potential of IBRX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than IBRX and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. Follow Insider Monkey on Google News.